Crystal Structure of Vδ1 T Cell Receptor in Complex with CD1d-Sulfatide Shows MHC-like Recognition of a Self-Lipid by Human γδ T Cells  by Luoma, Adrienne M. et al.
Immunity
ArticleCrystal Structure of Vd1 T Cell Receptor in Complex
with CD1d-Sulfatide Shows MHC-like Recognition
of a Self-Lipid by Human gd T Cells
Adrienne M. Luoma,1,2 Caitlin D. Castro,2 Toufic Mayassi,1,3 Leslie A. Bembinster,2 Li Bai,4,5,6 Damien Picard,5,6
Brian Anderson,7 Louise Scharf,2 Jennifer E. Kung,2 Leah V. Sibener,2 Paul B. Savage,7 Bana Jabri,1,3 Albert Bendelac,1,5,6
and Erin J. Adams1,2,*
1Committee on Immunology, University of Chicago, Chicago, IL 60637, USA
2Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL 60637, USA
3Department of Medicine, University of Chicago, Chicago, IL 60637, USA
4Institute of Immunology, School of Life Sciences, University of Science and Technology of China, Hefei 230027, China
5Department of Pathology, University of Chicago, Chicago, IL 60637, USA
6Howard Hughes Medical Institute
7Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA
*Correspondence: ejadams@uchicago.edu
http://dx.doi.org/10.1016/j.immuni.2013.11.001SUMMARY
The nature of the antigens recognized by gd T cells
and their potential recognition of major histocompat-
ibility complex (MHC)-like molecules has remained
unclear. Members of the CD1 family of lipid-present-
ing molecules are suggested ligands for Vd1 TCR-
expressing gd T cells, the major gd lymphocyte
population in epithelial tissues. We crystallized a
Vd1 TCR in complex with CD1d and the self-lipid
sulfatide, revealing the unusual recognition of CD1d
by germline Vd1 residues spanning all complemen-
tarity-determining region (CDR) loops, as well as
sulfatide recognition separately encoded by non-
germline CDR3d residues. Binding and functional
analysis showed that CD1d presenting self-lipids,
including sulfatide, was widely recognized by gut
Vd1+ gd T cells. These findings provide structural
demonstration of MHC-like recognition of a self-lipid
by gd T cells and reveal the prevalence of lipid recog-
nition by innate-like T cell populations.
INTRODUCTION
There are twomajor lineages of T lymphocytes, ab and gd T cells,
which are defined by their T cell receptor (TCR) gene-segment
usage. Although the ab subset is the prominent T cell population
devoted to the orchestration of the adaptive immune response
in the circulation and lymph nodes, gd T cells are particularly
abundant in peripheral tissues, most notably the skin and intes-
tinal epithelium, where theymonitor early signs of tissue infection
or stress (Vantourout and Hayday, 2013). The coexistence of
two main T cell lineages has been conserved throughout
vertebrate evolution, highlighting how each plays an important,
nonredundant role in host defense and survival.
In humans there are two main populations of gd T cells, Vd1
and Vd2 T cells, which predominate in the epithelium and circu-1032 Immunity 39, 1032–1042, December 12, 2013 ª2013 Elsevier Inlation, respectively (McVay and Carding, 1999). It is hypothe-
sized that the TCR dependence of tissue localization might be
linked to recognition of a conserved tissue-specific self-ligand,
highlighting the importance of gd TCR ligand characterization
for our understanding of gd T cell biology. However, these
ligands remain poorly characterized in both the murine and
human systems, and those that have been described exhibit
strikingly little overlap between species (Vantourout and Hayday,
2013). Most identified ligands are self-derived and stress
induced, in accord with an important role for gd T cells in the early
detection of tissue damage. Such ligands include nonclassical
MHC-like molecules, such as murine T22, which has previously
been the only ligand for which structural studies have revealed
the mode of TCR recognition (Adams et al., 2005; Bonneville
et al., 1989; Spada et al., 2000; Willcox et al., 2012). Other
proposed ligands bear no resemblance to MHC molecules
(Constant et al., 1994; Scotet et al., 2005; Zeng et al., 2012). In
humans, intestinal epithelial Vd1+ cells have been shown to
respond to the stress-induced MHC-like molecules MHC class
I-related chain A (MICA) and MICB, though the role of the gd
TCR in this response has been controversial because of the
very low affinity of the interaction and because of competitive
MICA recognition by other surface receptors, such as natural
killer group 2, member D (NKG2D) (Bauer et al., 1999; Groh
et al., 1998; Xu et al., 2011).
One of the few reported human gd TCR ligands verified in
several independent studies is the lipid-presenting MHC-like
molecule CD1d. CD1d is a well-characterized TCR ligand for
natural killer T (NKT) cells of the ab T cell lineage, specializing
in the presentation of both self-derived and foreign lipids (Ross-
john et al., 2012). However, NKT cells are more than 10-fold less
abundant in humans than in mice, and although the full extent of
CD1d recognition by gd T cells has yet to be determined, gd
T cells appear to be a substantial complement to NKT cells
in the surveillance of lipid antigens (Bendelac et al., 2007).
CD1d-mediated lipid-antigen recognition has been described
for gd T cells in both the circulation and the intestinal epithelium
(Agea et al., 2005; Bai et al., 2012; Mangan et al., 2013; Russano
et al., 2007). These cells predominantly use the Vd1 TCR genec.
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specific cells among the less prevalent Vd3+ T cell population
(Mangan et al., 2013). Lipid-specific Vd1+ T cells exhibit hetero-
geneous phenotypes, which seem to vary according to tissue
residence. Circulating phospholipid-specific gd T cells have a
Th2-polarized phenotype, whereas those of intestinal origin can
mediate Th1-polarized or regulatory cytokine secretion (Agea
et al., 2005; Russano et al., 2006; Russano et al., 2007). The lipid
repertoire surveyed by Vd1+ T cells comprises both exogenous
pollen-derived phospholipids and self-lipids, including the
glycolipid sulfatide, which is enriched in neuronal, kidney, and
intestinal epithelial tissue (Bai et al., 2012; Breimer et al., 2012;
Russano et al., 2006; Takahashi andSuzuki, 2012). The detection
of self-ligands coincides with the roles of tissue-resident gd
T cells in tissue homeostasis and repair yet, conversely, might
explain the accumulation of these T cells in tissues in the context
of autoimmune pathology (Komano et al., 1995; Selmaj et al.,
1991; Toulon et al., 2009; Wucherpfennig et al., 1992).
Despite these studies implicating gd T cells as an important
lipid-reactive T cell population with diverse functional roles, the
structural basis of CD1d-lipid recognition is unknown, as it is for
all human gd TCRs. In stark contrast, abundant structural studies
have revealed the details of the ab TCR interaction with multiple
ligand classes (Borg et al., 2007; Garcia et al., 1996; Lo´pez-Saga-
seta et al., 2013). Here we provide the structural basis of human
gd TCR recognition and show how gd TCRs detect ligands in
the context of an antigen-presenting molecule, revealing a new
paradigm for the antigen specificity of Vd1+ T cells.
RESULTS
Vd1+ T Cells Recognize CD1d Directly through
the gd TCR
We have previously described two peripheral-blood-derived
CD1d-sulfatide-reactive human Vd1+ clones, the Vg4Vd1
DP10.7 and Vg5Vd1 AB18.1 TCRs (Figure 1A) (Bai et al., 2012).
To determine whether this interaction is specifically mediated
by the Vd1+ gd TCR, we used biochemical methods to measure
the interaction between soluble, recombinant CD1d loaded
with sulfatide and Vd1+ gd TCRs. CD1d loadedwith endogenous,
insect-cell-derived lipids (unloaded) failed to bind to the DP10.7
TCR (the equilibrium dissociation constant, Kd, was not measur-
able), whereas it bound to the AB18.1withmoderate affinity (Kd =
20.6 mM) (Figures 1B and 1C). Loading with mixed bovine brain
sulfatides (predominantly 24:0 and 24:1 acyl chains) dramatically
enhanced CD1d binding to the DP10.7 TCR (Kd = 5.5 mM) and
moderately affected binding to the AB18.1 TCR (Kd = 8.9 mM).
Both clones bound to CD1d loaded with 24:1 sulfatide (acyl
chain 24:1) at affinities comparable to those found with mixed
sulfatides (DP10.7 Kd = 5.6 mM; AB18.1 Kd = 13.9 mM). The
inability of the DP10.7 clone to bind to 24:1 bGalCer-loaded
CD1d (Kd > 100 mM) showed that the sulfate moiety was
essential for recognition given that bGalCer lacks the 30-galac-
tose sulfate group characteristic of sulfatide lipids. In line
with sulfatide’s having a secondary role in recognition by the
AB18.1 TCR, the absence of the 30 sulfate group only moderately
affected AB18.1 binding (Kd = 16.8 mM). Thus, the DP10.7 TCR
makes energetically important contacts with the sulfatide anti-
gen, whereas the AB18.1 TCR can recognize CD1d moleculesImmlargely indiscriminately of lipid antigens. Thus, it is likely that
variability in CDR3d loop or g chain sequences modulates Vd1+
TCR engagement of CD1d-lipid surfaces (Figure 1A).
The reactivity of Vd1+ T cells toward CD1d molecules loaded
with endogenous membrane lipids has been demonstrated pre-
viously (Russano et al., 2007), corroborating our biochemical
characterization of endogenous CD1d-presented-lipid recogni-
tion by the AB18.1 TCR. Beause the DP10.7 TCR exhibits
exquisite sulfatide-specific reactivity, we confirmed the func-
tional basis of this interaction by TCR transduction of Jurkat
J.RT3-T3.5 T cells. Clone JR.2, a control Vd1 TCR reported to
recognize CD1c molecules (Spada et al., 2000), did not respond
to plate-bound CD1d molecules with or without sulfatide
loading. However, transduction of the DP10.7 TCR conferred a
sulfatide-specific response correlating to the amount of CD1d
immobilization, as measured by CD69 upregulation (Figure 1D).
The higher basal expression of CD69 by DP10.7 TCR-trans-
duced cells in the presence of sulfatide most likely stems from
the expression of CD1d on Jurkat cells themselves (Metelitsa
et al., 2001). Together, these results demonstrate that Vd1+
T cells recognize and respond to CD1d-sulfatide directly through
the gd TCR.
Functional Characterization of CD1d-Sulfatide-Specific
Vd1+ T Cells
To understand markers associated with CD1d-sulfatide-specific
T cells, we performed phenotypic studies on Vd1+ T cells isolated
from the blood by CD1d-sulfatide tetramer MACS enrichment
and FACS sorting (Bai et al., 2012). Like many gd T cells, they
expressed CD8ab or CD8aa or were CD8 negative (Figure S1A
in the Supplemental Data available with this article online). In
agreement with the sequencing results demonstrating that these
cells were the progeny of expanded T cell clones, the fresh cells
exhibited a CD45RA+CD62LCCR7CD28 effector phenotype.
Notably, given the preeminence of Vd1+ T cells in the human gut,
these sulfatide-specific T cells isolated from the blood did not
express CD103, a marker for cells of intestinal origin. However,
they expressed the myeloid markers CD16, CD11b, and
CD11c in the two individuals examined (Figure S1A).
The rarity of CD1d-sulfatide-specific T cells in the blood
precluded an analysis of their functional properties, such as
cytokine secretion or cytolytic functions, directly ex vivo.
Nevertheless, experiments carried out with clones DP10.7 and
AB18.1 demonstrated predominant secretion of TNF-a and
IFN-g but little IL-4, IL-13, or IL-10, thus indicating a Th1 pheno-
type, upon stimulation with ionomycin and PMA (Figure S1B).
The Structural Basis for Vd1+ gd TCR Recognition
of CD1d-Sulfatide
To understand the molecular basis for Vd1 TCR recognition of
CD1d-sulfatide, we sought to crystallize the TCR-CD1d-sulfa-
tide ternary complex. We developed a fusion human-mouse
CD1d molecule (CD1dma3) in which the native human ligand-
binding a1 and a2 domains were fused with the murine a3
domain and heterodimerized with murine b2-microgobulin
(b2m). We undertook these efforts because of the many pub-
lished murine CD1d structures and the hypothesis that murine
CD1d molecules might crystallize more readily (Rossjohn et al.,
2012). This substitution did not affect DP10.7 TCR recognitionunity 39, 1032–1042, December 12, 2013 ª2013 Elsevier Inc. 1033
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Figure 1. CD1d-Sulfatide Recognition by Human Vd1+ T Cells is TCR Dependent
(A) CDR-loop amino acid sequences of two CD1d-sulfatide-specific Vd1 clones (DP10.7 and AB18.1).
(B) Surface plasmon resonance (SPR) binding responses of CD1d purified with endogenous lipids (unloaded) or loaded with indicated sulfatide variants to
C-terminally biotinylated DP10.7 and AB18.1 TCRs immobilized on a streptavidin Biacore chip. Response units of CD1d binding (0.258 mM) after reference
channel subtraction are shown.
(C) Equilibrium affinity analysis of DP10.7 and AB18.1 TCR binding to indicated CD1d forms.
(D) Percent CD69 upregulation on DP10.7 TCR-transduced Jurkat J.RT3-T3.5 T cells stimulated by plate-bound CD1d purified with endogenous lipids (white
circles) or loaded with sulfatide (gray circles). A control JR.2 TCR, which is CD1c specific, was similarly transduced and stimulated with CD1d presenting
endogenous lipids (white diamonds) or CD1d-sulfatide (gray diamonds) (see also Figure S1).
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CD1dma3-sulfatide complex (Figures S2A and S2B and Table
S1). These results confirmed that the structure of our fusion
was identical to the native human CD1d structure, particularly
within the human a1 and a2 domains (Figure S2B). The electron
density for sulfatide was unambiguous, revealing a stabilizing
network of hydrogen bonds with CD1d as described for murine
structures (Figures S2C and S2D) (Zajonc et al., 2005). In our
structure, the sulfatide head-group was displaced by >4 A˚ in
comparison with the murine CD1d-sulfatide structure because
a tryptophan residue, rather than a glycine residue, was present
in the human form (Figure S2E). This provides direct evidence
that human and mouse CD1d molecules can differ in their pre-
sentation of the same lipid.1034 Immunity 39, 1032–1042, December 12, 2013 ª2013 Elsevier InTo crystalize the ternary complex of the DP10.7 TCR, human
CD1d, and sulfatide, we utilized the single-chain (sc) TCR
version, in which the variable domains are expressed as a fusion
protein. This strategy has been used previously for both ab and
gd TCR crystallization (Maynard et al., 2005; Xu et al., 2011). We
succeeded in crystallizing the ternary scDP10.7 TCR-CD1dma3-
24:1 sulfatide complex and determined its structure to 3.0 A˚
resolution (Table S1).
Exclusive d-Chain-Mediated Recognition
of CD1d-Sulfatide
The DP10.7 TCR docks at a tilted angle, such that all CDR loops
from the d chain contact the CD1d-sulfatide complex and there
is no contribution from the g chain (Figure 2A). In fact, therec.
AB
C
Figure 2. Complex Structure of DP10.7 TCR and CD1d-Sulfatide
Reveals Exclusive d Chain Dependence
Overview of DP10.7 TCR-CD1d-sulfatide complex and contacts.
(A) CD1d heterodimer, light gray; sulfatide, yellow; and DP10.7 TCR g-chain
and d-chain, light teal and violet, respectively. The side view (left) of the
complex shows a tilted TCR docking angle, which restricts CD1d-sulfatide
contacts to the d chain. The front view (right) shows the orientation of TCR
over the CD1d A0 pocket.
(B) The surface of CD1d-sulfatide is shown in white, and residues that contact
the TCR are colored according to CDR loop (residues % 4.0 A˚ from TCR).
CD1d residues contacted by CDR1d, CDR2d, and CDR3d are shown in green,
marine blue, and purple, respectively. CD1d residues contacted by multiple
CDR andHV4 loop residues are shown in orange. Atoms of sulfatide contacted
by CDR3d shown as purple spheres.
(C) The surface of CD1d-sulfatide is shown in white, and residues (CD1d) or
atoms (sulfatide) that contact the TCR are colored according to germline
origin, nongermline origin, or both in light yellow, red, and light orange,
respectively (see also Figure S2 and Table S1).
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Immare no g chain residues within 5 A˚ of the CD1d-sulfatide surface.
This dominance of the d chain is consistent with our mutagen-
esis, discussed below, and the exclusive use of the Vd1 domain
in gd T cells that respond to CD1d (Agea et al., 2005; Bai et al.,
2012; Russano et al., 2007). The d chain docks above the
CD1d A0 pocket, which binds the acyl 24:1 chain of sulfatide
(Figure 2A). The Vd1-encoded residues of the CDR1, CDR2,
and HV4d loops make contacts nearly exclusively with the a2
helix of CD1d (Figure 2B). The CDR3d loop largely contacts the
a1 helix of CD1d and the sulfatide head group but also shares
some contacts with those of the other CDR and HV loops. The
sulfatide antigen is contacted solely by junctional CDR3d loop
residues (Figure 2C), suggesting that other CD1d-restricted
Vd1 T cells might share this common docking footprint and utilize
recombined CDR3d loops to detect different lipid antigens.
The buried surface area (BSA) of the DP10.7 TCR-CD1d-
sulfatide interface is 730 A˚2, with 600 A˚2 from the TCR-CD1d
interface and 130 A˚2 from the TCR-sulfatide interface. This inter-
face is the smallest reported among TCR-ligand structures; it is
slightly less than that of iNKT TCR-CD1d-aGalCer complexes
(Pellicci et al., 2009) and considerably smaller than that of the
murine type II NKT TCR-CD1d-sulfatide complex, (1010 A˚2),
although the affinity is about three times higher (Patel et al.,
2012). Numerous ionic interactions in the DP10.7 TCR-CD1d-
sulfatide interface most likely compensate for the smaller inter-
face area to facilitate a higher-affinity interaction.
Comparisons with other TCR-ligand complex structures
reveal that the DP10.7 TCR engages CD1d-sulfatide with a
unique docking footprint. The murine G8-T22 complex is the
only other gd TCR structure with bound ligand, and it is similarly
dominated by d chain interactions (Adams et al., 2005). However,
the DP10.7 footprint is more evenly divided among all d chain
loops, rather than nearly exclusively relying on the CDR3d loop
as in G8-T22. (Figures 3A and 3B). The DP10.7 TCR footprint is
also distinct from the recognition mode of CD1d-restricted
type I and II NKT TCRs. The DP10.7 TCR contacts CD1d only
through the d chain; this bias in CD1d docking contrasts with
the distribution of CD1d contacts across both the a and b chains
in NKT cell recognition. However, the DP10.7 TCR docks above
the CD1d A0 pocket in an orientation that is overall similar to that
of the type II NKT TCR (Figures 3A and 3D) (Girardi et al., 2012;
Patel et al., 2012). Similarly, both the DP10.7 and type II NKT
TCRs contact lipid antigens with their recombined CDR3 loops,
in contrast to the invariant germline CDR1a loop-mediated lipid
contacts made by type I NKT TCRs (Figures 3A, 3C and 3D)
(Borg et al., 2007; Rossjohn et al., 2012). Because CDR3d loops
have the most potential sequence diversity among all recom-
bined immunoreceptors (Davis and Bjorkman, 1988), the central
orientation of the CDR3d over the CD1d antigen-binding pocket
suggests the potential of Vd1 TCRs to engage a diverse array of
lipid antigens.
TCR Contacts with CD1d Are Germline Encoded,
Whereas CDR3d Junctional Residues Contact Sulfatide
Electron density for all DP10.7 CDR loop residues and the sulfa-
tide ligand were unambiguous, permitting detailed analysis of
the TCR-CD1d-sulfatide interface (Figure S2 and Table S2).
We also performed TCR alanine mutagenesis and entire CDR
loop-swapping experiments via a tetramer-binding assay tounity 39, 1032–1042, December 12, 2013 ª2013 Elsevier Inc. 1035
A B C D Figure 3. The Vd1 DP10.7 TCREmploys a Unique
Docking Mode
(A) View of TCR variable domains (top) in complex with
a1, a2 domains of ligands and CDR loop footprint and
docking orientation (bottom) of TCR-ligand complexes.
(B) Murine G8 gd TCR-T22 complex (Protein Data Bank
accession code 1YPZ).
(C and D) Human iNKT TCR-CD1d-aGalCer complex
(Protein Data Bank accession code 2PO6) (C) and mu-
rine type II NKT TCR-CD1d-sulfatide complex (Protein
Data Bank accession code 4EI5) (D).
The surface of ligand a1, a2 domains is shown in white;
lipid ligands, if present, are shown in yellow. The TCR g
chain is shown in light teal, and the d chain is shown in
violet (A and B); the TCR-a chain is shown in green, and
the b chain is shown in blue (C and D). Grey lines
represent vector connecting the conserved disulfide
bond in each V domain (see also Table S2).
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accounts for 32% of the total BSA, most of which is contributed
by Trp30 (Figure 4A). This residue makes extensive nonpolar
contacts, most prominently a p-stacking interaction with
Trp160. Additional hydrogen bonds are formed by the CDR1d
Trp30 and Ser31 with CD1d Thr157 and Glu156, respectively
(Figure 4A). The importance of this loop is validated by the
observed reduction in binding when the unrelated Vd2-encoded
CDR1d is grafted in its place. (Figure 4D; see also Table S3).
Alanine mutagenesis revealed that several residues other than
the key Trp30 and Ser31 were important for binding, and these
residues probably affect the overall loop conformation (Fig-
ure 4E). Although the CDR2d loop is docked toward the outside
of the CD1d a2 helix and contributes only 11% toward the total
BSA, it forms many polar and ionic contacts with CD1d. Asp54
is at the center of a network of salt bridges that make these con-
tacts with Lys152 and Arg155 (Figure 4B). Ser53 is positioned to
engage in several hydrogen bonds with Glu156 and Lys152.
Alanine mutagenesis validates the contribution of these key
CDR2d residues (Figure 4E). Lys69 of the TCR HV4d loop also
contributes to this network of polar contacts by forming a salt
bridge with Glu156. The numerous specific Vd1 interactions
with CD1d highlight the strongly biased usage of this gene
segment in described CD1d-reactive gd TCRs (Agea et al.,
2005; Bai et al., 2012; Russano et al., 2007), whereas CD1d-
sulfatide reactive type II NKT TCRs can use several different
Va and Vb genes for CD1d recognition (Park et al., 2001).
In contrast, the extended CDR3d loop forms fewer polar
contacts with CD1d, although overall it plays a key role in
CD1d-sulfatide recognition, as shown in our structure and by a
marked reduction in binding upon substitution of this loop with
an unrelated CDR3d loop sequence (Figures 4C and 4D; see
also Table S3). The tip of the CDR3d is composed of Dd
segment-encoded residues Tyr98 and Trp99, which make
several VdW interactions with CD1d residues concentrated in
the a1 helix (Figure 4C). Tyr98 contributes a main-chain
hydrogen bond to Trp153 of the a2 helix via its backbone
carbonyl, but otherwise no polar contacts are made by the
five Dd2 and Dd3 residues of the CDR3d loop. As such, alanine
mutagenesis of Dd-encoded residues minimally affected binding
to CD1d-sulfatide (Figures 4D and 4E). All polar contacts with1036 Immunity 39, 1032–1042, December 12, 2013 ª2013 Elsevier Inthe sulfatide antigen are mediated by junctionally encoded resi-
dues Phe101 and Arg103, which form a main-chain hydrogen
bond and salt bridge, respectively, with the sulfate moiety
(Figure 4C). Alanine mutagenesis of these residues shows an
individually modest contribution, whereas dual Phe101 and
Arg103 mutagenesis reduces CD1d binding nearly as much as
swapping the entire CDR3d loop (Figures 4D and 4E). This cor-
roborates the key role of sulfatide interactions demonstrated
by SPR measurements (Figures 1B and 1C). Overall, there
were no residues that were absolutely required for CD1d-sulfa-
tide recognition, in contrast to the conserved ‘‘hot-spot’’
residues characteristic of T22-reactive TCRs (Adams et al.,
2008; Sandstrom et al., 2012). Our structure shows an inter-
woven network of contacts, and it is likely that compensatory
interactions can substitute for single alanine mutations. Further-
more, our tetramer-based detection has an avidity affect, so
smaller differences in binding might be partially masked. How-
ever, the observed binding reductions, such as for alanine
substitution of Asp54 and Arg103, were reproducible and corre-
late to their importance in our complex structure.
In accordance with structural studies, swapping entire g chain
CDR loops with unrelated sequences has no effect on CD1d-
sulfatide binding (Figure 4D; see also Table S3). Although the g
chain lacks energetic contributions here, it remains possible
that g chain CDR loops could mediate contacts of bulkier
CD1d-presented lipid antigens, such as the gangliosides com-
mon in nervous tissue (Haig et al., 2011; Tettamanti et al., 1973).
Minimal Conformational Change by the DP10.7 TCR
upon CD1d-Sulfatide Ligation
Conformational change during binding can play a large role in ab
TCR recognition of peptide-MHC, particularly in the CDR3 loops
that reorganize to optimally contact peptide antigens (Garcia
and Adams, 2005); however, a lack of structural data makes it
unclear whether gd TCRs require the same flexibility in recogni-
tion of their ligand. To address this question, we solved the
unliganded structure of the DP10.7 TCR, resolved to 3.3 A˚
resolution. Despite the moderate resolution limit, we were able
to model the backbones for all d chain CDR loops and most
side chains (Table S3 and Figure S4A). Despite participating
in crystal contacts, the CDR loop structures were essentiallyc.
AD E
B C Figure 4. Analysis of DP10.7 TCR-CD1d-
Sulfatide Contacts
(A–C) Polar contacts are shown in dashed black
lines; charges are indicated so that salt-bridge
contacts are emphasized. CD1d shown in light
gray, sulfatide is shown in yellow, TCR germline
residues are shown in violet, and nontemplated
residues in red for CDR1d (A); CDR2d and HV4 (B);
and CDR3d (C) contacts.
(D and E) TCR mutagenesis and binding mea-
surements were determined by a plate-binding
assay. ELISA plate wells were coated with WT or
mutant single-chain (sc) TCRs, and binding to
CD1d-sulfatide tetramers labeled with HRP was
measured by colorimetric readout (A450).
Nonspecific binding to BSA was subtracted, and
binding was calculated as a percentage of WT
binding. Shown are the mean and SEM of at least
two independent experiments. (D) Entire CDR
loops were substituted with unrelated CDR loop
sequences, and binding was compared with that
of the WT DP10.7 TCR. Double-alanine mutations
of indicted CDR3d-loop residues were also
analyzed. (E) Single alanine point mutations of
the DP10.7 TCR d chain were made, and binding
versus that of WT TCR was measured as above
(see also Figure S3 and Table S3).
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that they adopt similar rigid conformations (Figure 5A). Side
chain conformations did vary, most notably for the CDR2d resi-
due D54, which flipped about 180 in order to form salt bridges
with CD1d a2 helix residues Arg155 and Lys152 in the complex
structure (Figure 5B). Within the CDR3d loop, the side chain
of Arg103 moves 1A˚ closer to the sulfatide head group upon
binding in order to fall within salt-bridge distance (Figure 5C).
Otherwise, residues in the unliganded DP10.7 TCR are posi-
tioned to optimally form contacts as found in the complex
structure, indicative of a more rigid-body type interaction.
We also solved the structure of the AB18.1 TCR in the unli-
ganded form. This structure provides additional insight into
how Vd1 TCRs might be preoriented for CD1d recognition
(Table S1). Superimposition of this structure with the liganded
DP10.7 again reveals nearly identical conformation of the
CDR1,2 and HV4d loops (Figure S4B). However, the AB18.1
TCR CDR3d loop contains an intervening residue before the
conserved YWG motif (Figure 1A), and thus the loop is in a
somewhat different conformation (Figure S4C). Accommoda-
tion of the extra residue in the CDR3d loop would require
conformational changes upon CD1d-sulfatide binding if this
TCR were to dock in a similar manner. However, the key salt
bridge mediated by Arg103 in the DP10.7 structure would be
lost if AB18.1 were docked in a similar fashion because, despite
His104’s potentially yielding a positive charge, its position is too
far from the sulfate to form a salt bridge. This is in line with the
AB18.1 TCR’s recognizing CD1d-sulfatide with only a slightly
higher affinity than it does the ‘‘unloaded’’ CD1d molecule.
The potentially closer proximity of several CDR3d residues
with the a1 and a2 helices of CD1d might explain the ability
of the AB18.1 TCR to bind CD1d independently of sulfatide
loading, although a substantial shift in docking and g chain con-
tacts cannot be ruled out given that it is unknown whether theImmDP10.7 docking mode is conserved among this and other Vd1
TCRs. Overall, the conformations of the germline Vd1 loops
from two different unbound TCRs match up nearly identically
with that of the TCR in complex, despite different crystal pack-
ing, highlighting how these loops are preoriented for CD1d
recognition.
Broad Recognition of CD1d among Vd1 Clones
The exclusive Vd1-residue-mediated recognition of CD1d re-
vealed by our complex structure led us to investigate the preva-
lence of CD1d restriction among other human Vd1+ T cells. Vd1+
T cells comprise a prominent proportion of MS plaque-infiltrating
gd T cells and are found at high percentages within healthy
intestinal epithelial tissues. To test whether these T cells can
recognize CD1d-sulfatide, we produced TCRs derived from
published Vd1 sequences of multiple sclerosis (MS) plaque-infil-
trating and intestinal biopsy-derived gd lymphocytes and
measured their binding to CD1d-sulfatide tetramers (Figure S4A)
(Chowers et al., 1994; Wucherpfennig et al., 1992). Because only
d chain sequences were provided, we paired these with the
DP10.7 TCR g chain, which we showed to be irrelevant in
CD1d recognition. Thus, use of the DP10.7 TCR g chain allowed
an analysis of d-chain-exclusive interactions. This analysis does
not, however, rule out contributions from the natively paired g
chains (advantageous or deleterious). Our analysis of two MS
plaque clones demonstrated moderate to low binding to
CD1d sulfatide; although this is most likely reflective of a low
binding affinity, it establishes a basal recognition that might
be enhanced by g chain contributions, providing a possible link
between Vd1+ T cell infiltration of MS plaques, CD1d expression,
and the particular enrichment of sulfatide lipids in neuronal tis-
sues (Takahashi and Suzuki, 2012).
In contrast to the moderate binding of TCRs from MS pla-
ques, there was a striking prevalence of robust CD1d-sulfatideunity 39, 1032–1042, December 12, 2013 ª2013 Elsevier Inc. 1037
A B C Figure 5. Minimal Conformation Change
Required for CD1d-Sulfatide Recognition
(A) Free TCR (chain B, orange) was aligned to
bound TCR (purple) shown with CD1d (light gray)-
sulfatide (yellow) complex. d chain CDR loops of
free and bound TCR are shown over the CD1d
surface.
(B and C) CDR2-d- and CDR3-d-loop side chains
that make rearrangements upon ligation are high-
lighted (see also Figure S4).
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Self-lipid Recognition by gd T Cellsinteractions among TCRs from intestinally derived clones; some
of these TCRs were bound as strongly as the DP10.7 TCR.
Overall, those with shorter and more positively charged loops
bound most strongly (Figure 6A; see also Figure S5A). We
used biolayer interferometry (BLI) to measure a 25.8 mM
CD1d-sulfatide affinity for the most highly binding clone,
OJ33, and found that it was well within the 1–50 mM range of
agonist TCR-ligand affinities (Figure S5B and S5C) (van der
Merwe and Davis, 2003). This clone also bound unloaded
CD1d with a moderate affinity (41.5 mM, Figures S5B and
S5C). Despite our small sample size in this initial characteriza-
tion, these results clearly show a potential for CD1d restriction
among intestinal Vd1 clones and specifically for CD1d recogni-
tion of sulfatide lipid antigens.
We then examined the potential for CD1d recognition among
clones (paired d and g chains) previously characterized as
recognizing other nonclassical MHC molecules. The clones
IDP2 and d1A/B-3 have been described as being specific for
CD1c and MHC-class-I-related chain A (MICA), respectively
(Brenner et al., 1986; Groh et al., 1998; Porcelli et al., 1989),
although measurements of TCR interactions are either lacking
or very weak (Xu et al., 2011). The d1A/B-3 clone is the most
well studied among a population of intraepithelial lymphocytes
(IELs) that are reactive to MICA (Groh et al., 1998). Using the
above tetramer-based assay, we found that IDP2 bound negli-
gibly to CD1d-sulfatide, but surprisingly, the d1A/B-3 clones
bound in a similar range as the DP10.7 TCR (Figure 6A). We
validated this interaction by BLI affinity measurements and
calculated a Kd of 33.9 mM (Figures 6B and 6C). The d1A/B-3
TCR affinity for unloaded CD1d was almost 10-fold less (Kd =
241.3 mM), indicating that this TCR makes energetically impor-
tant sulfatide-specific contacts (Figures 6B and 6C). Alignment
with the complexed DP10.7 TCR demonstrates that d1A/B-3
sulfatide specificity is probably conferred by the CDR3d residue
Arg99, which is essentially superimposable with that of the key
DP10.7 sulfatide contact Arg103 and could readily form a salt
bridge with the sulfate moiety upon adoption of a different
rotamer (Figure S5D). Validating published results showing
that the d1A/B-3 TCR binds MICA with very low affinity (Kd =
100-900 mM) (Xu et al., 2011), we observed very weak binding
to MICA and were unable to accurately calculate an equilib-
rium affinity at the TCR concentrations used (Figures 6B and
6C). These results highlight the germline-encoded specificity
of Vd1 TCRs for CD1d molecules and demonstrate that this
recognition is broadly distributed across blood- and gut-resident
Vd1 T cells.1038 Immunity 39, 1032–1042, December 12, 2013 ª2013 Elsevier InGut-Derived Vd1+ T Cells Are Stimulated by CD1d
and Produce TNF-a
To further explore the recognition of CD1d in Vd1 T cells in the
gut, we purified IELs from jejunal biopsies (Jabri et al., 2000)
and sorted them on the basis of expression of the Vd1 TCR.
We expanded these cells in an unbiased, CD1d-nonspecific
manner by using irradiated feeder cells (Jabri et al., 2002)
to generate enough cells for functional characterization. The
expanded polyclonal cells uniformly expressed gd TCRs con-
taining a Vd1 chain (Figure 7A). When stimulated with increasing
concentrations of an anti-gd TCR antibody, approximately one-
fifth of the Vd1 population produced TNF-a in response (Fig-
ure 7B), consistent with the TNF-a secretion noted in the
characterization of blood Vd1 by PMA-ionomycin treatment
(Figure S1B). The effector activity of the remaining 80% of the
Vd1 polyclonal population is unknown but suggests a diverse
effector response to TCR triggering of this population.
Using CD1d-transfected C1R cells as targets, we sought to
determine whether CD1d could stimulate TNF-a production
from this Vd1 polyclonal population. To differentiate the Vd1
response to CD1d presenting endogenous phospholipids
(as documented in Russano et al. [Russano et al., 2007]) from
that of CD1d presenting sulfatide on the C1R cells, we first
established the loading efficiency of sulfatide in the C1R-CD1d
transfectants used for these experiments. To do so, we took
advantage of the exquisite specificity of the DP10.7 TCR to
CD1d-sulfatide by generating tetramers of this TCR for use as
a CD1d-sulfatide-specific staining reagent. Staining of unloaded
C1R-CD1d transfectants expressing endogenous antigens with
the DP10.7 TCR tetramer showed no surface staining, consistent
with our SPR experiments presented in Figure 1, showing no
detectable binding between the DP10.7 TCR and CD1d present-
ing endogenous lipid (‘‘unloaded’’). In contrast, nearly 100% of
C1R-CD1d transfectants loaded with sulfatide stained strongly
positive for the DP10.7 TCR tetramer (Figure 7C). This suggests
that our protocol for loading C1R-CD1d transfectants with
sulfatide effectively saturates the cell-surface CD1d with sulfa-
tide, thus allowing us to discriminate the Vd1 response against
CD1d-sulfatide from that of CD1d presenting endogenous lipids.
We then measured the TNF-a response of the polyclonal
Vd1 cells to CD1d, either loaded with sulfatide or presenting
endogenous lipids (‘‘unloaded’’). After 16 hr, approximately
4% of Vd1 T cells were producing TNF-a in response to C1R
cells transfected with CD1d presenting endogenous lipids,
as measured by intracellular cytokine staining (Figure 7D),
consistent with the reactivity noted by Spinozzi and colleaguesc.
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Figure 6. Widespread Recognition of CD1d-
Sulfatide by Vd1+ T Cells
(A) Assay of CD1d-sulfatide tetramer binding to
plate-bound scTCRs. CD1d-sulfatide tetramers
were labeled with HRP for colorimetric readout.
Nonspecific binding to BSA was subtracted, and
binding was calculated as a percentage of that to
DP10.7 TCR. Shown are the mean and SEM of at
least two independent experiments.
(B) BLI analysis of d1A/B-3 scTCR binding to im-
mobilized CD1d-sulfatide, unloaded CD1d (CD1d-
UL), or MICA. TCR concentrations ranged from
1.88–60 mM (CD1d-sulfatide andCD1d-UL) or from
10–80 mM (MICA). Shown are representative data
from one of two experiments.
(C) Equilibrium affinity analysis of (B). Shown are
the equilibrium binding mean and standard devi-
ation from two experiments, as well as fits used for
calculation of Kd values (see also Figure S5).
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Self-lipid Recognition by gd T Cells(Russano et al., 2007). In response to C1R cells transfected with
CD1d and loaded with sulfatide, approximately 2% of these cells
stained positive for TNF-a production. Considering that20% of
this polyclonal Vd1 population produces TNF-a in response to
TCR triggering and correcting for the background 1% of TNF-a
detected in mock-treated cells (Figure 7D, top), we can approxi-
mate that 15% of TNF-a producing Vd1 cells in this population
respond to CD1d presenting endogenous lipids and 5%
respond to CD1d presenting sulfatide. After 24 hr the measured
amount of TNF-a secreted in the supernatant of Vd1 cells re-
sponding to the CD1d-endogenous versus CD1d-sulfatide sam-
ples were following a trend similar to that found with intracellular
cytokinestaining (Figure7E). Together, these resultsdemonstrate
that a population of Vd1 T cells in the gut respond to CD1d pre-
senting endogenous antigens, including the lipid sulfatide.
DISCUSSION
One of the prevalent ideas about gd T cell recognition is that it is
antibody-like in nature, in contrast with peptide-MHC-specific
ab TCRs, which share an evolutionarily conserved, germline-
encoded footprint upon the MHC surface (Born et al., 2013;
Garcia and Adams, 2005; Marrack et al., 2008). This observation
about gd TCR recognition has arisen from the diverse structural
nature of previously described gd TCR ligands, many of which
have been ascribed to singular TCR clones (Vantourout and
Hayday, 2013). However, given the limited number of V gene
segments available for gd TCR recombination, it is plausible
that a fewmajor ligands dominate among the potential repertoire
of recognizable antigens, such as T22 for the murine T22-reac-
tive population (Adams et al., 2005; Shin et al., 2005) and
MICA and phosphorylated small molecules for human Vd1 and
Vd2 TCRs, respectively. However, a clear gd V segment-directed
recognition of an antigen-presenting molecule has yet to be
explicitly demonstrated. Our structure reveals the molecular
basis for this association and shows how the recombined
CDR3d loop mediates fine antigen specificity in a manner akin
to that of classical ab TCRs.Immgd T cells are particularly abundant among intraepithelial
T cells of the small intestine and colon. Numerous studies have
demonstrated that this population exhibits a crucial role in the
preservation of the epithelial barrier via production of both tissue
repair and inflammatory antimicrobial factors (Smith and Garrett,
2011). Given that the human gd IEL population exhibits a sub-
stantial Vd1 TCR cell bias, an important question remains as to
whether these functions are controlled through TCR recognition
of specific antigens. We examined a set of previously described
human intestinal clones and found not only that these TCRs
were CD1d specific but also that they recognized the self-lipid
sulfatide. In addition, we demonstrate that a sizable percent of
jejunally derived Vd1 T cells producing TNF-a (15%) are
responsive to CD1d presenting endogenous lipids and that
5% respond to CD1d presenting sulfatide. We cannot defini-
tively conclude that these cells are specific to sulfatide because
it is clear that some Vd1 T cells (such as the AB18.1 T cell clone
isolated from the blood) can recognize CD1d independently of
lipids, yet it is unlikely that all of these CD1d-sulfatide-reactive
T cells are lipid independent. Furthermore, we have only as-
sessed one effector output (TNF-a production); it is possible
that other cytokines are being produced by some of the remain-
ing 80% of Vd1 T cells in this population in response to CD1d
stimulation.
Among the TCRs that we identified as CD1d specific, the
most striking was the IEL clone d1A/B-3 (Groh et al., 1998).
This and other Vd1+ IEL clones have been described as being
MICA reactive, and MICA is a widely acknowledged Vd1 TCR
ligand (Vantourout and Hayday, 2013). Our results showed
that the d1A/B-3 TCR binds with appreciable affinity to
CD1d-sulfatide, suggesting this could be an alternative stimu-
latory TCR ligand for MICA-reactive T cells. Because the
MICA-specific costimulatory receptor NKG2D is ubiquitously
expressed among Vd1+ gd T cells and binds MICA with high af-
finity, it would effectively out compete the low binding affinity of
the d1A/B-3 TCR for MICA recognition (Groh et al., 2001; Wu
et al., 2002; Xu et al., 2011). MICA cell-surface expression
and NKG2D engagement occurs only during cellular stressunity 39, 1032–1042, December 12, 2013 ª2013 Elsevier Inc. 1039
Figure 7. Reactivity of Gut Vd1+ T Cells
to CD1d Presenting Endogenous Lipids,
Including Sulfatide
(A) Flow-cytometry contour plots showing CD3
and gd TCR expression of a polyclonal Vd1 IEL cell
line (top) and Vd1 versus Vd2 TCR expression
(bottom).
(B) Flow-cytometry contour plots of TNF-a intra-
cellular-cytokine staining of a polyclonal Vd1 IEL
cell line stimulated with increasing concentrations
of anti-gd TCR antibody. The concentration of
antibody is indicated at the top of each plot, and
the displayed percentages indicate cells gated for
TNF-a expression.
(C) Flow-cytometry histogram plot of DP10.7 TCR
tetramer staining of C1R mock transfectant
(shaded black), unloaded C1R-CD1d transfectant
(gray line), or C1R-CD1d transfectant treated with
30 mg/ml sulfatide (black line). The percentage of
tetramer-positive cells is indicated above the
drawn gate.
(D) Flow-cytometry contour plots of intracellular
TNF-a staining after 16 hr of coculture of a poly-
clonal Vd1 IEL cell line with C1R mock trans-
fectants (top), unloaded C1R-CD1d transfectants
(middle), and C1R-CD1d transfectants loaded with
sulfatide (bottom).
(E) Bar graph showing TNF-a levels measured in
the culture supernatant by ELISA after 24 hr of
coculture of a polyclonal Vd1 IEL cell line with
C1R-mock, unloaded C1R-CD1d, and C1R-CD1d
sulfatide transfectants.
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Self-lipid Recognition by gd T Cells(Groh et al., 1999; Meresse et al., 2004); therefore, this
signaling pathway might only be relevant during disease condi-
tions. However the constitutive expression of CD1d in human
intestinal epithelial cells (IECs) (Dougan et al., 2007; Perera
et al., 2007), between which IEL stably reside, and the enrich-
ment of endogenous lipids such as sulfatide in these tissues,
(Breimer et al., 2012) might provide a range of signals to Vd1+
IELs; these signals might be homeostatic in healthy tissue
and inflammatory when paired with MICA-NKG2D in a disease
setting.
CD1 molecules were among the first described ligands for gd
T cells, yet the field of CD1-lipid recognition largely diverted
to the study of ab T cells with the discovery of NKT cells (Bend-
elac et al., 1995; Porcelli et al., 1989). IELs within the intestine
are one of the largest T cell populations in humans, and of
these IELs, gd T cells comprise almost 40% (Cheroutre, 2005;
Deusch et al., 1991). Our results and those from others have
shown that human Vd1+ T cells and, as shown more recently,
Vd3+ T cells can recognize CD1d-lipid antigens, implicating1040 Immunity 39, 1032–1042, December 12, 2013 ª2013 Elsevier Inc.gd T cells as the largest lipid-reactive
population in humans (Agea et al., 2005;
Bai et al., 2012; Mangan et al., 2013;
Russano et al., 2007; Spada et al.,
2000). Although we have demonstrated
sulfatide recognition by several Vd1
clones, the potential for reactivity toward
lipids with diverse chemical natures is
clearly suggested by our structure, inwhich the recombined CDR3d loop is positioned over the
central lipid portal. Our results suggest that the prevalence
of lipid recognition among all Vd1+ T cell populations should
be re-examined.
EXPERIMENTAL PROCEDURES
CD1d, MICA, and TCR Cloning, Expression, and Purification
These protocols are described in detail in the Supplemental Experimental
Procedures.
Surface Plasmon Resonance
All SPR measurements were conducted with a Biacore 2000 instrument
operated at 25C. Eight hundred response units (RUs) of each TCR
were immobilized on a streptavidin sensor chip; one flow cell was left blank
for reference subtraction. All flow cells were then blocked with 1 mM biotin.
Serial dilutions of CD1d (unloaded or loaded with indicated lipids) from 8
to 0.25 mM were flowed as analyte. Equilibrium dissociation constants
were determined by nonlinear regression with GraphPad (Prism) software
and a shared Bmax because identical immobilizations of the TCRs
were used.
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Self-lipid Recognition by gd T CellsJurkat Transductions and Plate-Stimulation Assays
The full-length d and g chains of the DP10.7 TCR and a control Vd1 TCR JR.2
were cloned into pMSCV vectors (a gift of M. Kuhns) and retrovirally trans-
duced into TCRb-Jurkat J.RT3-T3.5 cells. To measure CD1d-sulfatide-
specific stimulation, we coated 96-well flat-bottomed plates with purified
WT humanCD1d in the indicated amounts (0–10 mg/well) at 37C for 2 hr.Wells
were washed, and bovine brain sulfatides (Maytreya, 100 mg/ml) or DMSO
control was added for 3 hr at 37C. Wells were washed and 5 3 104 DP10.7
or JR.2 TCR J.RT3-T3.5 transductants were added for a 12 hr incubation.
Activation was measured by CD69 expression (FN50, Biolegend).
Crystallization, Structure Determination, Refinement, and Analysis
These protocols are described in detail in the Supplemental Methods.
CD1d Tetramer Production, Plate Binding, and BLI Measurements
of TCRs
These protocols are described in detail in the Supplemental Experimental
Procedures.
Vd1 IEL Cell Line Characterization and Stimulation
Intraepithelial lymphocytes were purified from a jejunal biopsy as described
(Jabri et al., 2000) (details are available in the Supplemental Experimental
Procedures).
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